{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T18:09:20Z","timestamp":1772734160578,"version":"3.50.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-026-06439-3","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:10:29Z","timestamp":1772730629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From mechanism to clinic: a panoramic perspective on targeting HMOX1 to overcome drug resistance"],"prefix":"10.1007","volume":"152","author":[{"given":"Dan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"6439_CR1","doi-asserted-by":"publisher","unstructured":"Ahmad IM et al (2021) Heme Oxygenase-1 Inhibition potentiates the effects of Nab-Paclitaxel-Gemcitabine and modulates the tumor microenvironment in pancreatic ductal adenocarcinoma. Cancers (Basel) 13(9). https:\/\/doi.org\/10.3390\/cancers13092264","DOI":"10.3390\/cancers13092264"},{"issue":"1","key":"6439_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.gendis.2022.12.013","volume":"11","author":"D Ajmeera","year":"2024","unstructured":"Ajmeera D, Ajumeera R (2024) Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance. Genes Dis 11(1):148\u2013175. https:\/\/doi.org\/10.1016\/j.gendis.2022.12.013","journal-title":"Genes Dis"},{"issue":"2","key":"6439_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1165\/rcmb.2006-0340TR","volume":"36","author":"J Alam","year":"2007","unstructured":"Alam J, Cook JL (2007) How many transcription factors does it take to turn on the Heme oxygenase-1 gene? Am J Respir Cell Mol Biol 36(2):166\u2013174. https:\/\/doi.org\/10.1165\/rcmb.2006-0340TR","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"30","key":"6439_CR4","doi-asserted-by":"publisher","first-page":"21894","DOI":"10.1016\/S0021-9258(19)36696-7","volume":"267","author":"J Alam","year":"1992","unstructured":"Alam J, Den Z (1992) Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse Heme oxygenase-1 gene. J Biol Chem 267(30):21894\u201321900","journal-title":"J Biol Chem"},{"issue":"4","key":"6439_CR5","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1158\/2159-8290.Cd-20-1638","volume":"11","author":"M Aldea","year":"2021","unstructured":"Aldea M et al (2021) Overcoming resistance to Tumor-Targeted and Immune-Targeted therapies. Cancer Discov 11(4):874\u2013899. https:\/\/doi.org\/10.1158\/2159-8290.Cd-20-1638","journal-title":"Cancer Discov"},{"issue":"1","key":"6439_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","volume":"19","author":"NK Altorki","year":"2019","unstructured":"Altorki NK et al (2019) The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer 19(1):9\u201331. https:\/\/doi.org\/10.1038\/s41568-018-0081-9","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"6439_CR7","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1161\/atvbaha.118.311832","volume":"38","author":"M Andreas","year":"2018","unstructured":"Andreas M et al (2018) Intravenous Heme arginate induces HO-1 (Heme Oxygenase-1) in the human heart. Arterioscler Thromb Vasc Biol 38(11):2755\u20132762. https:\/\/doi.org\/10.1161\/atvbaha.118.311832","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"38","key":"6439_CR8","doi-asserted-by":"publisher","first-page":"33580","DOI":"10.1074\/jbc.M111.248401","volume":"286","author":"P Banerjee","year":"2011","unstructured":"Banerjee P et al (2011) The Heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-apoptotic signal. J Biol Chem 286(38):33580\u201333590. https:\/\/doi.org\/10.1074\/jbc.M111.248401","journal-title":"J Biol Chem"},{"key":"6439_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2022.06.226","volume":"188","author":"B Bathish","year":"2022","unstructured":"Bathish B et al (2022) Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2. Free Radic Biol Med 188:221\u2013261. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.06.226","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"6439_CR10","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1158\/1078-0432.Ccr-04-2159","volume":"11","author":"PO Berberat","year":"2005","unstructured":"Berberat PO et al (2005) Inhibition of Heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res 11(10):3790\u20133798. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-04-2159","journal-title":"Clin Cancer Res"},{"issue":"3","key":"6439_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"6439_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071801","author":"G Canesin","year":"2021","unstructured":"Canesin G et al (2021) Cancer Growth Cells 10(7). https:\/\/doi.org\/10.3390\/cells10071801. HO-1 and Heme: G-Quadruplex Interaction Choreograph DNA Damage Responses"},{"issue":"6","key":"6439_CR13","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/s0168-8278(03)00095-3","volume":"38","author":"L Cantoni","year":"2003","unstructured":"Cantoni L et al (2003) Induction of hepatic Heme oxygenase-1 by diclofenac in rodents: role of oxidative stress and cytochrome P-450 activity. J Hepatol 38(6):776\u2013783. https:\/\/doi.org\/10.1016\/s0168-8278(03)00095-3","journal-title":"J Hepatol"},{"issue":"1","key":"6439_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s40001-024-01930-4","volume":"29","author":"Y Chen","year":"2024","unstructured":"Chen Y et al (2024) Baicalin promotes the sensitivity of NSCLC to cisplatin by regulating ferritinophagy and macrophage immunity through the KEAP1-NRF2\/HO-1 pathway. Eur J Med Res 29(1):387. https:\/\/doi.org\/10.1186\/s40001-024-01930-4","journal-title":"Eur J Med Res"},{"key":"6439_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12929-016-0219-6","volume":"23","author":"CC Cheng","year":"2016","unstructured":"Cheng CC et al (2016) Blocking Heme oxygenase-1 by zinc protoporphyrin reduces tumor hypoxia-mediated VEGF release and inhibits tumor angiogenesis as a potential therapeutic agent against colorectal cancer. J Biomed Sci 23:18. https:\/\/doi.org\/10.1186\/s12929-016-0219-6","journal-title":"J Biomed Sci"},{"issue":"1","key":"6439_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12935-025-03908-6","volume":"25","author":"Z Cheng","year":"2025","unstructured":"Cheng Z et al (2025) Heme oxygenase-1 leads to cisplatin resistance in nasopharyngeal carcinoma by reducing oxidative stress and ferroptosis. Cancer Cell Int 25(1):302. https:\/\/doi.org\/10.1186\/s12935-025-03908-6","journal-title":"Cancer Cell Int"},{"key":"6439_CR17","doi-asserted-by":"publisher","unstructured":"Chiang SK et al (2018) A dual role of Heme Oxygenase-1 in cancer cells. Int J Mol Sci 20(1). https:\/\/doi.org\/10.3390\/ijms20010039","DOI":"10.3390\/ijms20010039"},{"issue":"1","key":"6439_CR18","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1186\/s12951-025-03680-9","volume":"23","author":"A Chill\u00e0","year":"2025","unstructured":"Chill\u00e0 A et al (2025) Sparking angiogenesis by carbon monoxide-rich gold nanoparticles obtained by pulsed laser driven CO(2) reduction reaction. J Nanobiotechnol 23(1):590. https:\/\/doi.org\/10.1186\/s12951-025-03680-9","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"6439_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12950-025-00467-5","volume":"22","author":"P Chudy","year":"2025","unstructured":"Chudy P et al (2025) Effect of Heme oxygenase-1 on the expression of interferon-stimulated genes. J Inflamm (Lond) 22(1):43. https:\/\/doi.org\/10.1186\/s12950-025-00467-5","journal-title":"J Inflamm (Lond)"},{"issue":"1","key":"6439_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2021.10.004","volume":"8","author":"SJ Cowman","year":"2022","unstructured":"Cowman SJ, Koh MY (2022) Revisiting the HIF switch in the tumor and its immune microenvironment. Trends Cancer 8(1):28\u201342. https:\/\/doi.org\/10.1016\/j.trecan.2021.10.004","journal-title":"Trends Cancer"},{"key":"6439_CR21","doi-asserted-by":"publisher","first-page":"115061","DOI":"10.1016\/j.bcp.2022.115061","volume":"201","author":"Q Cui","year":"2022","unstructured":"Cui Q et al (2022) Therapeutic implication of carbon monoxide in drug resistant cancers. Biochem Pharmacol 201:115061. https:\/\/doi.org\/10.1016\/j.bcp.2022.115061","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"6439_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.lungcan.2012.02.016","volume":"77","author":"MS Degese","year":"2012","unstructured":"Degese MS et al (2012) Expression of Heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data. Lung Cancer 77(1):168\u2013175. https:\/\/doi.org\/10.1016\/j.lungcan.2012.02.016","journal-title":"Lung Cancer"},{"issue":"5","key":"6439_CR23","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"6439_CR24","doi-asserted-by":"publisher","unstructured":"Du Y et al (2025) HMOX1\u2009+\u2009macrophages determine immunosuppressive microenvironment and immunotherapy efficacy in hepatocellular carcinoma. Hepatol Commun 9(11). https:\/\/doi.org\/10.1097\/hc9.0000000000000815","DOI":"10.1097\/hc9.0000000000000815"},{"issue":"2","key":"6439_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1161\/circulationaha.107.698316","volume":"117","author":"J Dulak","year":"2008","unstructured":"Dulak J et al (2008) Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117(2):231\u2013241. https:\/\/doi.org\/10.1161\/circulationaha.107.698316","journal-title":"Circulation"},{"key":"6439_CR26","doi-asserted-by":"publisher","first-page":"114542","DOI":"10.1016\/j.ejmech.2022.114542","volume":"239","author":"K Engle","year":"2022","unstructured":"Engle K, Kumar G (2022) Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update. Eur J Med Chem 239:114542. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114542","journal-title":"Eur J Med Chem"},{"key":"6439_CR27","doi-asserted-by":"publisher","first-page":"101293","DOI":"10.1016\/j.drup.2025.101293","volume":"83","author":"X Fan","year":"2025","unstructured":"Fan X et al (2025) HSA-templated synergistic platform boosts radiotherapy via enhanced radiosensitization and ferroptosis induction. Drug Resist Updat 83:101293. https:\/\/doi.org\/10.1016\/j.drup.2025.101293","journal-title":"Drug Resist Updat"},{"key":"6439_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.semcancer.2021.05.004","volume":"76","author":"AP Ferragut Cardoso","year":"2021","unstructured":"Ferragut Cardoso AP et al (2021) MiRNA dysregulation is an emerging modulator of genomic instability. Semin Cancer Biol 76:120\u2013131. https:\/\/doi.org\/10.1016\/j.semcancer.2021.05.004","journal-title":"Semin Cancer Biol"},{"key":"6439_CR29","doi-asserted-by":"publisher","first-page":"216826","DOI":"10.1016\/j.canlet.2024.216826","volume":"590","author":"GB Gao","year":"2024","unstructured":"Gao GB et al (2024) LncRNA RGMB-AS1 inhibits HMOX1 ubiquitination and NAA10 activation to induce ferroptosis in non-small cell lung cancer. Cancer Lett 590:216826. https:\/\/doi.org\/10.1016\/j.canlet.2024.216826","journal-title":"Cancer Lett"},{"key":"6439_CR30","doi-asserted-by":"publisher","first-page":"1594693","DOI":"10.3389\/fbioe.2025.1594693","volume":"13","author":"TB Gomes Araujo","year":"2025","unstructured":"Gomes Araujo TB et al (2025) Toxicity evaluation of laser-synthesized pro-angiogenic carbon monoxide-rich gold nanoparticles in vitro and in vivo. Front Bioeng Biotechnol 13:1594693. https:\/\/doi.org\/10.3389\/fbioe.2025.1594693","journal-title":"Front Bioeng Biotechnol"},{"issue":"11","key":"6439_CR32","doi-asserted-by":"publisher","first-page":"104161","DOI":"10.1016\/j.drudis.2024.104161","volume":"29","author":"Y Guo","year":"2024","unstructured":"Guo Y et al (2024) P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators. Drug Discov Today 29(11):104161. https:\/\/doi.org\/10.1016\/j.drudis.2024.104161","journal-title":"Drug Discov Today"},{"key":"6439_CR31","doi-asserted-by":"publisher","first-page":"103515","DOI":"10.1016\/j.redox.2025.103515","volume":"80","author":"Q Guo","year":"2025","unstructured":"Guo Q et al (2025) Applications and enhancement strategies of ROS-based non-invasive therapies in cancer treatment. Redox Biol 80:103515. https:\/\/doi.org\/10.1016\/j.redox.2025.103515","journal-title":"Redox Biol"},{"issue":"7679","key":"6439_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ et al (2017) Drug-tolerant persister cancer cells are vulnerable to GPX4 Inhibition. Nature 551(7679):247\u2013250. https:\/\/doi.org\/10.1038\/nature24297","journal-title":"Nature"},{"issue":"1","key":"6439_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12964-023-01398-5","volume":"22","author":"MJ Iqbal","year":"2024","unstructured":"Iqbal MJ et al (2024) Interplay of oxidative stress, cellular communication and signaling pathways in cancer. Cell Commun Signal 22(1):7. https:\/\/doi.org\/10.1186\/s12964-023-01398-5","journal-title":"Cell Commun Signal"},{"key":"6439_CR35","doi-asserted-by":"publisher","unstructured":"Jain S et al (2025) The paradox of Heme Oxygenase 1: from cellular defense to a tug of war between cancer promotion and prevention. Adv Biol (Weinh) e00390. https:\/\/doi.org\/10.1002\/adbi.202500390","DOI":"10.1002\/adbi.202500390"},{"issue":"4","key":"6439_CR36","doi-asserted-by":"publisher","first-page":"e1183","DOI":"10.1038\/cddis.2014.149","volume":"5","author":"KA Kang","year":"2014","unstructured":"Kang KA et al (2014) Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation. Cell Death Dis 5(4):e1183. https:\/\/doi.org\/10.1038\/cddis.2014.149","journal-title":"Cell Death Dis"},{"issue":"26","key":"6439_CR37","doi-asserted-by":"publisher","first-page":"40594","DOI":"10.18632\/oncotarget.9745","volume":"7","author":"KA Kang","year":"2016","unstructured":"Kang KA et al (2016) Interaction of DNA demethylase and histone methyltransferase upregulates Nrf2 in 5-fluorouracil-resistant colon cancer cells. Oncotarget 7(26):40594\u201340620. https:\/\/doi.org\/10.18632\/oncotarget.9745","journal-title":"Oncotarget"},{"key":"6439_CR38","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev.pharmtox.46.120604.141053","volume":"46","author":"HP Kim","year":"2006","unstructured":"Kim HP et al (2006) CO as a cellular signaling molecule. Annu Rev Pharmacol Toxicol 46:411\u2013449. https:\/\/doi.org\/10.1146\/annurev.pharmtox.46.120604.141053","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"6439_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/cpr.12228","volume":"49","author":"S Kongpetch","year":"2016","unstructured":"Kongpetch S et al (2016) Haem Oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice. Cell Prolif 49(1):90\u2013101. https:\/\/doi.org\/10.1111\/cpr.12228","journal-title":"Cell Prolif"},{"key":"6439_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-025-01229-3","author":"ZL Lamplugh","year":"2025","unstructured":"Lamplugh ZL et al (2025) Microenvironmental regulation of solid tumour resistance to CAR T cell therapy. Nat Rev Immunol. https:\/\/doi.org\/10.1038\/s41577-025-01229-3","journal-title":"Nat Rev Immunol"},{"issue":"13","key":"6439_CR41","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1073\/pnas.91.13.5987","volume":"91","author":"Y Lavrovsky","year":"1994","unstructured":"Lavrovsky Y et al (1994) Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human Heme Oxygenase 1 gene. Proc Natl Acad Sci U S A 91(13):5987\u20135991. https:\/\/doi.org\/10.1073\/pnas.91.13.5987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6439_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12967-021-02745-1","volume":"19","author":"J Li","year":"2021","unstructured":"Li J et al (2021a) Panaxydol attenuates ferroptosis against LPS-induced acute lung injury in mice by Keap1-Nrf2\/HO-1 pathway. J Transl Med 19(1):96. https:\/\/doi.org\/10.1186\/s12967-021-02745-1","journal-title":"J Transl Med"},{"issue":"40","key":"6439_CR43","doi-asserted-by":"publisher","first-page":"e2102046","DOI":"10.1002\/smll.202102046","volume":"17","author":"K Li","year":"2021","unstructured":"Li K et al (2021b) Functionalized tumor-Targeting nanosheets exhibiting Fe(II) overloading and GSH consumption for ferroptosis activation in liver tumor. Small 17(40):e2102046. https:\/\/doi.org\/10.1002\/smll.202102046","journal-title":"Small"},{"issue":"1","key":"6439_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","volume":"16","author":"M Li","year":"2023","unstructured":"Li M et al (2023) Metabolism, metabolites, and macrophages in cancer. J Hematol Oncol 16(1):80. https:\/\/doi.org\/10.1186\/s13045-023-01478-6","journal-title":"J Hematol Oncol"},{"issue":"1","key":"6439_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12943-025-02375-x","volume":"24","author":"X Liang","year":"2025","unstructured":"Liang X et al (2025) Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers. Mol Cancer 24(1):219. https:\/\/doi.org\/10.1186\/s12943-025-02375-x","journal-title":"Mol Cancer"},{"issue":"18","key":"6439_CR46","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/onc.2012.244","volume":"32","author":"PH Lin","year":"2013","unstructured":"Lin PH et al (2013) TRC8 suppresses tumorigenesis through targeting Heme oxygenase-1 for ubiquitination and degradation. Oncogene 32(18):2325\u20132334. https:\/\/doi.org\/10.1038\/onc.2012.244","journal-title":"Oncogene"},{"issue":"1","key":"6439_CR49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13046-023-02789-9","volume":"42","author":"T Liu","year":"2023","unstructured":"Liu T et al (2023) SENP5 promotes homologous recombination-mediated DNA damage repair in colorectal cancer cells through H2AZ desumoylation. J Exp Clin Cancer Res 42(1):234. https:\/\/doi.org\/10.1186\/s13046-023-02789-9","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"6439_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-023-01928-2","volume":"23","author":"H Liu","year":"2024","unstructured":"Liu H et al (2024a) Nasopharyngeal carcinoma: current views on the tumor microenvironment\u2019s impact on drug resistance and clinical outcomes. Mol Cancer 23(1):20. https:\/\/doi.org\/10.1186\/s12943-023-01928-2","journal-title":"Mol Cancer"},{"issue":"1","key":"6439_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13020-024-00881-6","volume":"19","author":"S Liu","year":"2024","unstructured":"Liu S et al (2024b) Sanguinarine chloride induces ferroptosis by regulating ROS\/BACH1\/HMOX1 signaling pathway in prostate cancer. Chin Med 19(1):7. https:\/\/doi.org\/10.1186\/s13020-024-00881-6","journal-title":"Chin Med"},{"issue":"1","key":"6439_CR50","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12964-024-01759-8","volume":"22","author":"W Liu","year":"2024","unstructured":"Liu W et al (2024c) Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1. Cell Commun Signal 22(1):378. https:\/\/doi.org\/10.1186\/s12964-024-01759-8","journal-title":"Cell Commun Signal"},{"issue":"13","key":"6439_CR52","doi-asserted-by":"publisher","first-page":"e18386","DOI":"10.1111\/jcmm.18386","volume":"28","author":"Z Liu","year":"2024","unstructured":"Liu Z et al (2024d) Plumbagin ameliorates LPS-induced acute lung injury by regulating PI3K\/AKT\/mTOR and Keap1-Nrf2\/HO-1 signalling pathways. J Cell Mol Med 28(13):e18386. https:\/\/doi.org\/10.1111\/jcmm.18386","journal-title":"J Cell Mol Med"},{"issue":"10","key":"6439_CR51","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.1097\/js9.0000000000002829","volume":"111","author":"Y Liu","year":"2025","unstructured":"Liu Y et al (2025) Distinct roles of HMOX1 on tumor epithelium and macrophage for regulation of immune microenvironment in ovarian cancer. Int J Surg 111(10):6725\u20136742. https:\/\/doi.org\/10.1097\/js9.0000000000002829","journal-title":"Int J Surg"},{"issue":"1","key":"6439_CR54","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41420-023-01752-z","volume":"9","author":"YY Lu","year":"2023","unstructured":"Lu YY et al (2023) Cepharanthine, a regulator of keap1-Nrf2, inhibits gastric cancer growth through oxidative stress and energy metabolism pathway. Cell Death Discov 9(1):450. https:\/\/doi.org\/10.1038\/s41420-023-01752-z","journal-title":"Cell Death Discov"},{"key":"6439_CR53","doi-asserted-by":"publisher","first-page":"156139","DOI":"10.1016\/j.phymed.2024.156139","volume":"135","author":"C Lu","year":"2024","unstructured":"Lu C et al (2024) Shikonin induces ferroptosis in osteosarcomas through the mitochondrial ROS-regulated HIF-1\u03b1\/HO-1 axis. Phytomedicine 135:156139. https:\/\/doi.org\/10.1016\/j.phymed.2024.156139","journal-title":"Phytomedicine"},{"key":"6439_CR55","doi-asserted-by":"publisher","first-page":"658315","DOI":"10.3389\/fimmu.2021.658315","volume":"12","author":"KN Luu Hoang","year":"2021","unstructured":"Luu Hoang KN et al (2021) The diverse roles of Heme Oxygenase-1 in tumor progression. Front Immunol 12:658315. https:\/\/doi.org\/10.3389\/fimmu.2021.658315","journal-title":"Front Immunol"},{"issue":"12","key":"6439_CR56","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1002\/ijc.34270","volume":"151","author":"S Magri","year":"2022","unstructured":"Magri S et al (2022) The immunosuppression pathway of tumor-associated macrophages is controlled by Heme oxygenase-1 in glioblastoma patients. Int J Cancer 151(12):2265\u20132277. https:\/\/doi.org\/10.1002\/ijc.34270","journal-title":"Int J Cancer"},{"key":"6439_CR57","doi-asserted-by":"publisher","unstructured":"Mancuso C (2025) The Heme Oxygenase\/Biliverdin reductase system and its genetic variants in physiology and diseases. Antioxid (Basel) 14(2). https:\/\/doi.org\/10.3390\/antiox14020187","DOI":"10.3390\/antiox14020187"},{"issue":"14","key":"6439_CR58","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1089\/ars.2019.7991","volume":"32","author":"MV Medina","year":"2020","unstructured":"Medina MV et al (2020) Regulation of the expression of Heme Oxygenase-1: signal Transduction, gene promoter Activation, and beyond. Antioxid Redox Signal 32(14):1033\u20131044. https:\/\/doi.org\/10.1089\/ars.2019.7991","journal-title":"Antioxid Redox Signal"},{"key":"6439_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.05.033","author":"J Mei","year":"2025","unstructured":"Mei J et al (2025) Heme Oxygenase 1 (HO-1) is a drug target for reversing cisplatin resistance in non-small cell lung cancer. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2025.05.033","journal-title":"J Adv Res"},{"key":"6439_CR60","doi-asserted-by":"publisher","DOI":"10.1039\/d5md00616c","author":"Y Men","year":"2025","unstructured":"Men Y et al (2025) Pan-cancer analysis reveals HMOX1 as a cancer prognosis and immune infiltration-related biomarker. RSC Med Chem. https:\/\/doi.org\/10.1039\/d5md00616c","journal-title":"RSC Med Chem"},{"issue":"10","key":"6439_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0159-1","volume":"50","author":"C M\u00e9ndez-Blanco","year":"2018","unstructured":"M\u00e9ndez-Blanco C et al (2018) Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors. Exp Mol Med 50(10):1\u20139. https:\/\/doi.org\/10.1038\/s12276-018-0159-1","journal-title":"Exp Mol Med"},{"issue":"6","key":"6439_CR62","first-page":"2145","volume":"30","author":"M Miyake","year":"2010","unstructured":"Miyake M et al (2010) Inhibition of Heme oxygenase-1 enhances the cytotoxic effect of gemcitabine in urothelial cancer cells. Anticancer Res 30(6):2145\u20132152","journal-title":"Anticancer Res"},{"key":"6439_CR63","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.freeradbiomed.2022.08.041","volume":"191","author":"R Moreno","year":"2022","unstructured":"Moreno R et al (2022) Biotinylation of an acetylenic tricyclic bis(cyanoenone) lowers its potency as an NRF2 activator while creating a novel activity against BACH1. Free Radic Biol Med 191:203\u2013211. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.08.041","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"6439_CR64","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1158\/1078-0432.Ccr-17-2587","volume":"24","author":"T Muliaditan","year":"2018","unstructured":"Muliaditan T et al (2018) Repurposing Tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer. Clin Cancer Res 24(7):1617\u20131628. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-2587","journal-title":"Clin Cancer Res"},{"issue":"3","key":"6439_CR65","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jconrel.2011.04.025","volume":"155","author":"H Nakamura","year":"2011","unstructured":"Nakamura H et al (2011) Intracellular uptake and behavior of two types zinc protoporphyrin (ZnPP) micelles, SMA-ZnPP and PEG-ZnPP as anticancer agents; unique intracellular disintegration of SMA micelles. J Control Release 155(3):367\u2013375. https:\/\/doi.org\/10.1016\/j.jconrel.2011.04.025","journal-title":"J Control Release"},{"key":"6439_CR66","doi-asserted-by":"publisher","first-page":"154701","DOI":"10.1016\/j.phymed.2023.154701","volume":"112","author":"M Ni","year":"2023","unstructured":"Ni M et al (2023) Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe(2+) accumulation. Phytomedicine 112:154701. https:\/\/doi.org\/10.1016\/j.phymed.2023.154701","journal-title":"Phytomedicine"},{"key":"6439_CR67","doi-asserted-by":"publisher","first-page":"1457010","DOI":"10.3389\/fimmu.2024.1457010","volume":"15","author":"SA O\u2019Rourke","year":"2024","unstructured":"O\u2019Rourke SA et al (2024) The Nrf2-HO-1 system and inflammaging. Front Immunol 15:1457010. https:\/\/doi.org\/10.3389\/fimmu.2024.1457010","journal-title":"Front Immunol"},{"key":"6439_CR68","doi-asserted-by":"publisher","first-page":"101097","DOI":"10.1016\/j.mam.2022.101097","volume":"86","author":"S Pan","year":"2022","unstructured":"Pan S, Chen R (2022) Pathological implication of protein post-translational modifications in cancer. Mol Aspects Med 86:101097. https:\/\/doi.org\/10.1016\/j.mam.2022.101097","journal-title":"Mol Aspects Med"},{"key":"6439_CR69","doi-asserted-by":"publisher","first-page":"100907","DOI":"10.1016\/j.drup.2022.100907","volume":"66","author":"K Pang","year":"2023","unstructured":"Pang K et al (2023) Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1\/PD-L1 Blockade. Drug Resist Updat 66:100907. https:\/\/doi.org\/10.1016\/j.drup.2022.100907","journal-title":"Drug Resist Updat"},{"key":"6439_CR70","doi-asserted-by":"publisher","unstructured":"Poudel P, Adhikari S (2022) Efficacy and safety concerns with Sn-Mesoporphyrin as an adjunct therapy in neonatal hyperbilirubinemia: A literature review. Int J Pediatr 2022(2549161). https:\/\/doi.org\/10.1155\/2022\/2549161","DOI":"10.1155\/2022\/2549161"},{"key":"6439_CR71","doi-asserted-by":"publisher","unstructured":"Ryter SW (2022) Heme Oxygenase-1: an anti-Inflammatory effector in Cardiovascular, Lung, and related metabolic disorders. Antioxid (Basel) 11(3). https:\/\/doi.org\/10.3390\/antiox11030555","DOI":"10.3390\/antiox11030555"},{"key":"6439_CR72","doi-asserted-by":"publisher","first-page":"103035","DOI":"10.1016\/j.redox.2024.103035","volume":"70","author":"M Shen","year":"2024","unstructured":"Shen M et al (2024) DNAJC12 causes breast cancer chemotherapy resistance by repressing doxorubicin-induced ferroptosis and apoptosis via activation of AKT. Redox Biol 70:103035. https:\/\/doi.org\/10.1016\/j.redox.2024.103035","journal-title":"Redox Biol"},{"issue":"6","key":"6439_CR73","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1159\/000374036","volume":"35","author":"L Shi","year":"2015","unstructured":"Shi L et al (2015) MiR-141 activates Nrf2-Dependent antioxidant pathway via Down-Regulating the expression of Keap1 conferring the resistance of hepatocellular carcinoma cells to 5-Fluorouracil. Cell Physiol Biochem 35(6):2333\u20132348. https:\/\/doi.org\/10.1159\/000374036","journal-title":"Cell Physiol Biochem"},{"key":"6439_CR74","doi-asserted-by":"publisher","first-page":"1224892","DOI":"10.3389\/fimmu.2023.1224892","volume":"14","author":"D Song","year":"2023","unstructured":"Song D et al (2023) The potential of activator protein 1 (AP-1) in cancer targeted therapy. Front Immunol 14:1224892. https:\/\/doi.org\/10.3389\/fimmu.2023.1224892","journal-title":"Front Immunol"},{"key":"6439_CR75","doi-asserted-by":"publisher","first-page":"101286","DOI":"10.1016\/j.drup.2025.101286","volume":"83","author":"F Song","year":"2025","unstructured":"Song F et al (2025) Targeted therapy in acute myeloid leukemia: resistance and overcoming strategy. Drug Resist Updat 83:101286. https:\/\/doi.org\/10.1016\/j.drup.2025.101286","journal-title":"Drug Resist Updat"},{"issue":"3","key":"6439_CR76","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s11033-020-05292-y","volume":"47","author":"M Spampinato","year":"2020","unstructured":"Spampinato M et al (2020) Non-competitive Heme oxygenase-1 activity inhibitor reduces non-small cell lung cancer glutathione content and regulates cell proliferation. Mol Biol Rep 47(3):1949\u20131964. https:\/\/doi.org\/10.1007\/s11033-020-05292-y","journal-title":"Mol Biol Rep"},{"issue":"7","key":"6439_CR77","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1002\/tox.24253","volume":"39","author":"Z Sun","year":"2024","unstructured":"Sun Z et al (2024) miR-29b-3p targetedly regulates VEGF to inhibit tumor progression and cisplatin resistance through Nrf2\/HO-1 signaling pathway in non-small cell lung cancer. Environ Toxicol 39(7):3956\u20133966. https:\/\/doi.org\/10.1002\/tox.24253","journal-title":"Environ Toxicol"},{"issue":"1","key":"6439_CR78","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/tp.0000000000000770","volume":"100","author":"RA Thomas","year":"2016","unstructured":"Thomas RA et al (2016) Hemin preconditioning upregulates Heme Oxygenase-1 in deceased donor renal transplant recipients: A Randomized, Controlled, phase IIB trial. Transplantation 100(1):176\u2013183. https:\/\/doi.org\/10.1097\/tp.0000000000000770","journal-title":"Transplantation"},{"key":"6439_CR79","doi-asserted-by":"publisher","first-page":"102124","DOI":"10.1016\/j.redox.2021.102124","volume":"46","author":"TT Tien Vo","year":"2021","unstructured":"Tien Vo TT et al (2021) The potentials of carbon monoxide-releasing molecules in cancer treatment: an outlook from ROS biology and medicine. Redox Biol 46:102124. https:\/\/doi.org\/10.1016\/j.redox.2021.102124","journal-title":"Redox Biol"},{"issue":"6","key":"6439_CR80","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13402-012-0105-5","volume":"35","author":"JR Tsai","year":"2012","unstructured":"Tsai JR et al (2012) High expression of Heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients. Cell Oncol (Dordr) 35(6):461\u2013471. https:\/\/doi.org\/10.1007\/s13402-012-0105-5","journal-title":"Cell Oncol (Dordr)"},{"issue":"7782","key":"6439_CR81","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan N et al (2019) A view on drug resistance in cancer. Nature 575(7782):299\u2013309. https:\/\/doi.org\/10.1038\/s41586-019-1730-1","journal-title":"Nature"},{"key":"6439_CR82","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-immunol-070621-030155","volume":"40","author":"MD Vesely","year":"2022","unstructured":"Vesely MD et al (2022) Resistance mechanisms to Anti-PD cancer immunotherapy. Annu Rev Immunol 40:45\u201374. https:\/\/doi.org\/10.1146\/annurev-immunol-070621-030155","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"6439_CR83","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","volume":"8","author":"N Wang","year":"2023","unstructured":"Wang N et al (2023) Targeting epigenetic regulators to overcome drug resistance in cancers. Signal Transduct Target Ther 8(1):69. https:\/\/doi.org\/10.1038\/s41392-023-01341-7","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"6439_CR84","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12951-025-03117-3","volume":"23","author":"X Wang","year":"2025","unstructured":"Wang X et al (2025) Bio-nanocomplexes impair iron homeostasis to induce non-canonical ferroptosis in cancer cells. J Nanobiotechnol 23(1):121. https:\/\/doi.org\/10.1186\/s12951-025-03117-3","journal-title":"J Nanobiotechnol"},{"issue":"11","key":"6439_CR86","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.7150\/ijbs.59404","volume":"17","author":"R Wei","year":"2021","unstructured":"Wei R et al (2021) Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells. Int J Biol Sci 17(11):2703\u20132717. https:\/\/doi.org\/10.7150\/ijbs.59404","journal-title":"Int J Biol Sci"},{"issue":"17","key":"6439_CR85","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1158\/0008-5472.Can-22-4017","volume":"83","author":"M Wei","year":"2023","unstructured":"Wei M et al (2023) SENP1 decreases RNF168 phase separation to promote DNA damage repair and drug resistance in colon cancer. Cancer Res 83(17):2908\u20132923. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-4017","journal-title":"Cancer Res"},{"issue":"Suppl 1","key":"6439_CR87","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1038\/jp.2010.173","volume":"31","author":"RJ Wong","year":"2011","unstructured":"Wong RJ et al (2011) In vitro Inhibition of Heme Oxygenase isoenzymes by metalloporphyrins. J Perinatol 31(Suppl 1):S35\u201341. https:\/\/doi.org\/10.1038\/jp.2010.173","journal-title":"J Perinatol"},{"key":"6439_CR88","doi-asserted-by":"publisher","unstructured":"Wu X et al (2025) Curcumin analogues trigger HMOX1-Mediated ferroptosis to halt endometrial cancer Growth. BioRxiv. https:\/\/doi.org\/10.1101\/2025.11.18.689080","DOI":"10.1101\/2025.11.18.689080"},{"issue":"8002","key":"6439_CR89","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-024-07103-x","volume":"627","author":"M Yamagishi","year":"2024","unstructured":"Yamagishi M et al (2024) Mechanisms of action and resistance in histone methylation-targeted therapy. Nature 627(8002):221\u2013228. https:\/\/doi.org\/10.1038\/s41586-024-07103-x","journal-title":"Nature"},{"key":"6439_CR90","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2022.06.010","volume":"188","author":"C Yang","year":"2022","unstructured":"Yang C et al (2022) Flavonoid 4,4\u2019-dimethoxychalcone induced ferroptosis in cancer cells by synergistically activating Keap1\/Nrf2\/HMOX1 pathway and inhibiting FECH. Free Radic Biol Med 188:14\u201323. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.06.010","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"6439_CR91","doi-asserted-by":"publisher","first-page":"e3488","DOI":"10.1002\/jgm.3488","volume":"25","author":"B Yao","year":"2023","unstructured":"Yao B et al (2023) BACH1 promotes intervertebral disc degeneration by regulating HMOX1\/GPX4 to mediate oxidative stress, ferroptosis, and lipid metabolism in nucleus pulposus cells. J Gene Med 25(6):e3488. https:\/\/doi.org\/10.1002\/jgm.3488","journal-title":"J Gene Med"},{"key":"6439_CR92","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/1471-2407-14-436","volume":"14","author":"H Yin","year":"2014","unstructured":"Yin H et al (2014) Upregulation of Heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity. BMC Cancer 14:436. https:\/\/doi.org\/10.1186\/1471-2407-14-436","journal-title":"BMC Cancer"},{"issue":"1","key":"6439_CR94","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41368-024-00305-z","volume":"16","author":"Z Yuan","year":"2024","unstructured":"Yuan Z et al (2024) Sinensetin protects against periodontitis through binding to Bach1 enhancing its ubiquitination degradation and improving oxidative stress. Int J Oral Sci 16(1):38. https:\/\/doi.org\/10.1038\/s41368-024-00305-z","journal-title":"Int J Oral Sci"},{"issue":"11","key":"6439_CR93","doi-asserted-by":"publisher","first-page":"16081","DOI":"10.1007\/s00210-025-04256-y","volume":"398","author":"J Yuan","year":"2025","unstructured":"Yuan J et al (2025) ML385 increases ferroptosis via inhibiting Nrf2\/HO-1 pathway to enhances the sensitivity of MCF-7 TAMR to Tamoxifen. Naunyn Schmiedebergs Arch Pharmacol 398(11):16081\u201316093. https:\/\/doi.org\/10.1007\/s00210-025-04256-y","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"35","key":"6439_CR95","doi-asserted-by":"publisher","first-page":"e202300379","DOI":"10.1002\/anie.202300379","volume":"62","author":"F Zeng","year":"2023","unstructured":"Zeng F et al (2023) Ferroptosis detection: from approaches to applications. Angew Chem Int Ed Engl 62(35):e202300379. https:\/\/doi.org\/10.1002\/anie.202300379","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"6439_CR96","doi-asserted-by":"publisher","first-page":"9050","DOI":"10.1038\/s41467-024-53233-1","volume":"15","author":"K Zhang","year":"2024","unstructured":"Zhang K et al (2024) Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer. Nat Commun 15(1):9050. https:\/\/doi.org\/10.1038\/s41467-024-53233-1","journal-title":"Nat Commun"},{"issue":"10","key":"6439_CR97","doi-asserted-by":"publisher","first-page":"e2206415","DOI":"10.1002\/smll.202206415","volume":"19","author":"J Zhao","year":"2023","unstructured":"Zhao J et al (2023) Clustered Cobalt nanodots initiate ferroptosis by upregulating Heme Oxygenase 1 for radiotherapy sensitization. Small 19(10):e2206415. https:\/\/doi.org\/10.1002\/smll.202206415","journal-title":"Small"},{"issue":"22","key":"6439_CR98","doi-asserted-by":"publisher","first-page":"e2206798","DOI":"10.1002\/advs.202206798","volume":"10","author":"C Zheng","year":"2023","unstructured":"Zheng C et al (2023) Donafenib and GSK-J4 synergistically induce ferroptosis in liver cancer by upregulating HMOX1 expression. Adv Sci (Weinh) 10(22):e2206798. https:\/\/doi.org\/10.1002\/advs.202206798","journal-title":"Adv Sci (Weinh)"},{"key":"6439_CR99","doi-asserted-by":"publisher","unstructured":"Zhou Q et al (2024) Propafenone facilitates mitochondrial-associated ferroptosis and synergizes with immunotherapy in melanoma. J Immunother Cancer 12(11). https:\/\/doi.org\/10.1136\/jitc-2024-009805","DOI":"10.1136\/jitc-2024-009805"},{"key":"6439_CR100","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jconrel.2024.11.048","volume":"377","author":"L Zhu","year":"2025","unstructured":"Zhu L et al (2025) Self-catalyzed nitric oxide nanocomplexes induce ferroptosis for cancer immunotherapy. J Control Release 377:524\u2013539. https:\/\/doi.org\/10.1016\/j.jconrel.2024.11.048","journal-title":"J Control Release"},{"issue":"1","key":"6439_CR101","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41420-025-02564-z","volume":"11","author":"L Zuo","year":"2025","unstructured":"Zuo L et al (2025) The Nrf2-HMOX1 pathway as a therapeutic target for reversing cisplatin resistance in non-small cell lung cancer via inhibiting ferroptosis. Cell Death Discov 11(1):287. https:\/\/doi.org\/10.1038\/s41420-025-02564-z","journal-title":"Cell Death Discov"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06439-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-026-06439-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06439-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:10:30Z","timestamp":1772730630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-026-06439-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":101,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["6439"],"URL":"https:\/\/doi.org\/10.1007\/s00432-026-06439-3","relation":{"references":[{"id-type":"doi","id":"10.3390\/cells10071801","asserted-by":"subject"}]},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"58"}}